Showing results (261-270 of 443) with videos related to
Sort By:
Pageof 45
Hepatology Communications|December 21, 2021
Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyMalik Janjua, Matthew Knuiman, Mark Divitini, et al.The American Journal of Gastroenterology|May 19, 2007
Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemiaAyako Suzuki, Paul Angulo, Jennifer St Sauver, et al.New Solutions : a Journal of Environmental and Occupational Health Policy : NS|December 2, 2025
Uncovering the Factors Behind Rising Pneumoconiosis Rates: Central Appalachian Underground Coal Miners as a Case StudyYi-Hsuan Chen, John-Paul Angulo, Jürgen F Brune, et al.Scandinavian Journal of Gastroenterology|April 24, 2012
A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver diseaseStephen P Casey, William W Kemp, Catriona A McLean, et al.Hepatology (Baltimore, Md.)|April 12, 2020
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-AnalysisShravan Dave, Sooyoung Park, M Hassan Murad, et al.Hepatology Communications|February 7, 2018
Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinomaLuis C Bertot, Gary P Jeffrey, Michael Wallace, et al.Hepatology (Baltimore, Md.)|December 16, 2017
Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitisAhmad Hassan Ali, James H Tabibian, Navine Nasser-Ghodsi, et al.Journal of Gastroenterology|January 15, 2020
An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohortZeinab Bakhshi, Moira B Hilscher, Gregory J Gores, et al.The Journal of Surgical Research|January 21, 2012
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferationRoberto Gedaly, Paul Angulo, Jonathan Hundley, et al.Hepatology International|June 26, 2023
Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver diseaseZhengyi Wang, Gary P Jeffrey, Yi Huang, et al.Pageof 45